Riskpilot← Back to searchSign inGet full accessEMPE Diagnostics AB
ABActiveOrg 5590281563Nobels Väg 16 3trResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20151-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
+88% vs 2023
Equity ratio
66.5%
Financial strength
Net profit 2024
SEK -1,8M
+84% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,3M | +88% |
| Net profit | SEK -1,8M | +84% |
| Total assets | SEK 13,2M | -40% |
| Equity | SEK 8,8M | +40% |
| Employees | — | — |
Legal name
EMPE Diagnostics AB
Org number
5590281563
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29 september 2015
Share capital
SEK 235 252
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva verksamhet inom bioteknik, forskning samt molekylär och biomedicinsk diagnostik och instrumentering samt därmed förenlig verksamhet.
Address
Nobels Väg 16 3tr
Email
pavan@empediagnostics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 50 | 78 | 0 |
| Staff expenses | — | — | — | — | −5 839 |
| EBITDA | −7 672 | −8 793 | −12 444 | −10 748 | −1 316 |
| Depreciation & amort. | −1 959 | −375 | −409 | −456 | −441 |
| EBIT | −9 631 | −9 168 | −12 853 | −11 204 | −1 757 |
| Net financials | −29 | −19 | −4 | 28 | −2 |
| Profit before tax | −9 660 | −9 187 | −12 857 | −11 177 | −1 759 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −9 660 | −9 187 | −12 857 | −11 177 | −1 759 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 27 505 | 25 852 | 39 481 | 22 131 | 13 234 |
| Equity | 25 585 | 16 693 | 17 470 | 6 294 | 8 794 |
| Long-term debt | 133 | 19 | 0 | 0 | — |
| Short-term debt | 1 787 | 9 141 | 22 010 | 15 837 | 4 440 |
| Total debt | 1 920 | 9 160 | 22 010 | 15 837 | 4 440 |
EBITDA margin
-131577000.0%
This company
15.8%
Market median
-832765923% vs market
20202024
Equity ratio
66.5%
This company
38.2%
Market median
+74% vs market
20202024
Return on equity
-20.0%
This company
18.4%
Market median
-209% vs market
20202024
Net profit margin
-175923400.0%
This company
8.1%
Market median
-2171893927% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CV Chief Auditor | Chief Auditor | 2021 |
JB Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (2) | ||
RG Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
PA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Former (5) | ||
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2020 – 2024 | |
| Chairman | 2020 – 2024 | |
| Board of Directors | 2020 – 2020 | |
| Chairman | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EMPE Diagnostics AB (this company)
Empe Diagnostics Private LimitedEMPE DIAGNOSTICS PRIVATE LIMITEDBoard members of EMPE Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carin Viola Christina Forsström | Chief Auditor | 0 companies |
| Raghavendra Goud Vaggu | Chief Executive Officer | 0 companies |
| Pavankumar Asalapuram Ramachandran | Deputy Chief Executive Officer | 0 companies |
| Jan Buch Andersen | Chief Executive Officer | 0 companies |
| Mikael Kubista | Board of Directors | 0 companies |
| Sven Erik Sigfrid Hoffner | Board of Directors | 0 companies |
| Jan Eric Mats Gullberg | Board of Directors | 0 companies |
| Ingrid Maria Salén | Chairman | 0 companies |
| Olle Wahlqvist | Chairman | 0 companies |
| Anders Ingemar Lundin | Board of Directors | 0 companies |
| Pär Lennart Nordström | Board of Directors | 0 companies |
| Catharina Elisabeth Lagerstam | Chairman | 0 companies |
| Mats Bo Johan Nilsson Bernitz | Board of Directors | 0 companies |